Celebrex Approved To Treat Juvenile Rheumatoid Arthritis

Fri, 29 Dec 2006 02:00 PM EST

... The U.S. Food and Drug Administration (FDA) today approved Celebrex (celecoxib) for a new use - the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older. Today's approval follows the November 29 meeting of FDA's Arthritis Advisory Committee, in which the committee voted 15 to 1 in favor of approval of this product. [click link for full article] ...